
Product highlights
- Plus adds integrated vLimeLite near-infrared fluorescence visualization and a 26-inch 3D HD screen. Overlay/greyscale modes, green/cyan ICG colours and console thumbstick control are described; availability remains subject to local authorization.
- The vision offering describes automatic video upload subject to a data-sharing agreement. Software updates and clinical/operational data apps are digital functions, not proof of autonomous surgical decision-making or improved patient outcomes.
- The Ultrasonic Dissector is an instrument with a reusable transducer and single-use sterile chassis. Manufacturer claims include vessels up to 5 mm, 250 minutes transducer activation and at most 25 reprocessing cycles; these are not whole-robot runtime, payload or an independent clinical guarantee. The manufacturer explicitly excludes US sale.
- FDA K252111 identifies Plus and documents NIR imaging, software and instrument changes relative to original DEN230078. The summary was prepared June 27, 2025 but clearance was December 16, 2025, with adult 22+ cholecystectomy scope at that time.
- FDA K261252 records a further Versius Plus decision on October 21, 2026. Exact changes to the indications were not established from the retrieved decision record; the December 2025 cholecystectomy scope is a historical milestone rather than an exhaustive statement of current labeling.
Product sources
- CMR Surgical — Versius Plus platform · Manufacturer source · Checked 2026-11-03
- CMR Surgical — Versius Plus vision and vLimeLite · Manufacturer source · Checked 2026-11-03
- CMR Surgical — Ultrasonic Dissector and regional limits · Manufacturer source · Checked 2026-11-03
- FDA — K252111 decision and Versius Plus 510(k) summary · Regulatory authority source · Checked 2026-11-03
- FDA — K252111 decision record · Regulatory authority source · Checked 2026-11-03
- FDA — K261252 Versius Plus decision record · Regulatory authority source · Checked 2026-11-03
Description
Distinct Versius Plus platform with modular bedside units, open surgeon console, a 26-inch 3D HD screen and integrated vLimeLite near-infrared ICG visualization. FDA K252111 cleared the Plus configuration on December 16, 2025 for adult 22+ cholecystectomy; K261252 records a further substantially-equivalent decision on October 21, 2026. Exact later indication changes were not established from the retrieved record and the older scope is not presented as exhaustive current labeling. Components and instruments retain local regulatory limits.
Specifications
Sources cover the marked fields only. Unmarked values have not been checked in this review; manufacturer figures are not independent test results.
| PriceSource review · | Not disclosed |
| Drive modeSource review · | Surgeon-controlled modular robot-assisted surgery with open console; portable bedside units, not self-driving operation |
| HandsSource review · | Detachable endoscopic surgical instruments; Ultrasonic Dissector availability is regional and is not approved for US sale |
